Banca Mediolanum (BMED) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
2 Jun, 2026Executive summary
Net income for Q1 2025 reached €243.3 million, up 10–10.4% year-over-year, driven by robust commercial momentum, resilient business model, and positive market effects despite a decline in net interest income.
Total net inflows surged 22.9–23% YoY to €3.77 billion, with managed asset inflows up 71% to €2.01 billion; April 2025 set a new record for managed asset inflows.
Customer base grew by 2% to over 1.96 million, supported by network expansion and promotional initiatives.
Loans granted in Q1 totaled €849 million, up 51% YoY; credit book reached €17.78 billion.
General insurance gross premium increased 26% YoY to €53.3 million.
Financial highlights
Net commission income rose 8.9–9% YoY to €316.2 million, while net interest income fell 18–18.2% YoY to €180 million due to rate changes and deposit promotions.
Contribution margin was €495 million; operating margin stable at €279 million.
Management and investment management fees increased 13% YoY to €410.5 million.
Performance fees reached €39.2 million (+32% YoY); market effects contributed €52 million (+106% YoY).
Total assets under administration and management rose to €140.3 billion, up 1–1.3% from year-end.
Outlook and guidance
2025 guidance: managed asset net inflows around €7.5 billion, NII to decrease ~5% YoY, cost/income ratio below 40%, cost of risk below 20bps, and base dividend to increase.
NII expected to improve sequentially through 2025; guidance assumes further deposit promotions.
Strategy focuses on organic growth, service quality, and strengthening the Family Banker network.
Latest events from Banca Mediolanum
- Net income up 18% to €674.3M, assets at €133B, CET1 at 23.4%, interim dividend approved.BMED
Q3 20242 Jun 2026 - Net income up 24% to €449.9M, CET1 at 23.7%, and managed asset inflows guidance raised.BMED
Q2 20242 Jun 2026 - Net income up 6% to €477.3M, with record assets, strong inflows, and robust capital ratios.BMED
Q2 20252 Jun 2026 - Q1 2026 net income up 13%, with strong margins, inflows, and robust capital ratios.BMED
Q1 20267 May 2026 - Record net income, strong asset growth, and a 25% higher dividend highlight a standout year.BMED
Q4 20253 Feb 2026 - Record net income of €1.12B, €10.44B inflows, and 42% higher dividend proposed.BMED
Q4 20248 Jan 2026 - Net income up 8% to €726M, assets at €150.4B, and interim dividend raised to €0.60/share.BMED
Q3 20258 Nov 2025